•
PT
PTGX
Protagonist Therapeutics, Inc
polygonPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
5.22B
Volume
1.09M
52W High
$96.54
52W Low
$33.70
Open
$82.51
Prev Close
$83.42
Day Range
80.27 - 83.96
About Protagonist Therapeutics, Inc
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
Latest News
Moody Aldrich Dumps Entire Stake in Chart Industries Worth $5.8 Million
The Motley Fool•Oct 23
Moody Aldrich Liquidates Entire Stake in PLMR Worth $8.2 Million
The Motley Fool•Oct 21
This 2.7%-Yielding Dividend King Remains One of the Healthiest Income Stocks You Can Buy
The Motley Fool•Oct 15
Johnson & Johnson To Separate Orthopedics Business, Boosts Annual Sales Outlook
Benzinga•Oct 14
FDA Adds New Warning For Johnson & Johnson's Cancer Cell Therapy
Benzinga•Oct 13
Douglas Lane Adds $6 Million in J&J Stock Ahead of Earnings and Possible Biotech Deal
The Motley Fool•Oct 12
Why Protagonist Therapeutics Stock Skyrocketed by Almost 30% Today
The Motley Fool•Oct 10
Johnson & Johnson In Talks To Acquire Protagonist Therapeutics: Report
Benzinga•Oct 10